HuagongsheHuagongshe Chemistry Print Report · For research reference only
1-Tert-butyl-4-[(trimethylstannyl)methylene]piperidine → 7-[(1-Tert-butylpiperidin-4-ylidene)methyl]-5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-1,6-naphthyridin-2(1h)-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 1-Tert-butyl-4-[(trimethylstannyl)methylene]piperidine | HCID 22647936 | — |
| Reactant | HCID 22647982 | HCID 22647982 | — |
| Product | 7-[(1-Tert-butylpiperidin-4-ylidene)methyl]-5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-1,6-naphthyridin-2(1h)-one | HCID 22647891 | — |
Reaction Steps
The title compound was prepared from 7-bromo-5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-1,6-naphthyridin-2(1H)-one (COMPOUND HHH2) and 1-tert-butyl-4-[(trimethylstannyl)methylene]piperidine (INTERMEDIATE ABA3)by a procedure analogous to that described in EXAMPLE HHH1, Step A. Mass spectrum (ESI) 554 (M+1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06809199B2 |
| Source dataset | uspto-grants-2004_10 |
| ORD ID | ord-24bdabdfad0b48fea3ab42ba12d36e74 |
| Source note | uspto-grants-2004_10 |